The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given ‘as needed’ in mild asthma: study protocols for two randomised controlled trials
Crossref DOI link: https://doi.org/10.1186/s13063-016-1731-4
Published Online: 2017-01-10
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
O’Byrne, Paul M.
FitzGerald, J. Mark
Zhong, Nanshan
Bateman, Eric
Barnes, Peter J.
Keen, Christina
Almqvist, Gun
Pemberton, Kristine
Jorup, Carin
Ivanov, Stefan
Reddel, Helen K.
Funding for this research was provided by:
AstraZeneca